Introduction {#Sec1}
============

As left ventricular (LV) function is an important predictor of clinical outcome in various systemic and congenital heart diseases, new echocardiographic modalities and techniques are developed to help accurate assessment of segmental and global myocardial deformation. The most recent development is the two-dimensional speckle-tracking echocardiography (2D STE), which is a relatively angle-independent method for assessing myocardial strain and is used to quantify deformation function \[[@CR1]--[@CR4]\]. STE has been shown accurate in detecting subclinical myocardial dysfunction when most of the conventional echocardiographic parameters were normal or reported inconsistent results \[[@CR5]\]. Likewise, detailed analysis of LV myocardial deformation in three-dimensional fashion carries the potential of providing a clearer understanding of segmental and regional function interaction in different diseases \[[@CR6], [@CR7]\]. However, routine application of myocardial strain in clinical practice requires clear definition of normal values and any associated variations. Of the commonest potential variables that may influence strain measurements, are patient demographics (age, gender and ethnicity) and clinical parameters (e.g. heart rate, weight, body surface area, blood pressure, LV volumes, LV dimensions and LV mass). Furthermore, technical variables i.e. vendor-customized software, probe frequency, tissue tracking and frame rate have been shown to play an important role in influencing absolute deformation measurements \[[@CR8]--[@CR10]\].

Objectives {#Sec2}
==========

The objective of this study was to conduct a meta-analysis of normal ranges of LV myocardial deformation measurements (strain and strain rate) derived from 2D STE in longitudinal, circumferential and radial planes in children and to identify confounders that may contribute to differences and variability in the reported measures.

Methods {#Sec3}
=======

MEDLINE, Embase, Scopus, Cochrane Central Register of Controlled Trials and ClinicalTrials.gov were searched using the key terms "strain", "speckle tracking", "2DSTE", "myocardial deformation", "echocardiography", "left ventricle", "children", "infant", "newborn","neonate", "toddler" and "adolescent". The search was completed in May 2015. No language filter was applied. Two investigators (HJ, PI) independently examined the resulted articles. To ensure accurate identification of all relevant articles, the reference lists of the articles were manually searched to further identify studies of interest that comply with the inclusion criteria.

Study selection {#Sec4}
---------------

Only articles reporting LV strain using 2D speckle-tracking echocardiography in normal healthy children were included. Also, this meta-analysis incorporated studies that explicitly described normal healthy subjects as well as observational studies that used control groups as a comparison for study population. Since myocardial deformation parameters were reported to change between different age groups, classifications previously used by Marcus et al. \[[@CR11]\] and Klitisie et al. \[[@CR12]\] (\<1 year, 1-4, 5-9, 10-14 and 15-19 years) were adopted. In addition, neonates were reported as a separate age group. Healthy controls from individual studies were then allocated in respective age groups based on their mean/average age.

The commonly used 2D STE measures included were LS (Longitudinal strain) and LSRs (Longitudinal systolic strain rate). Nine studies measured global longitudinal LV strain in apical long-axis and 2- and 4-chamber views using automated function imaging, a novel 2-dimensional speckle tracking algorithm (bull's eye). Other studies used only 4-chamber view to measure LS, which represents an average of three septal and three lateral segmental strains. Hence, in order to estimate LV longitudinal segmental strain, we averaged the values from the base, mid-cavity and apical segments of lateral and septal walls to obtain comparable patterns with the bull's eye model.

Since, global circumferential and radial strain was reported only in 8 and 3 datasets respectively, when also considering different age groups, it seemed not eligible for conducting a Meta analysis. However, circumferential and radial strain at the level of papillary muscles could be extracted from 24 and 18 datasets respectively, hence, Meta analysis of mid-level short axis deformation parameters was conducted.

GE echocardiograph was used in 24 studies, MyLab, Siemens and Philips in one study each. One study used three different types of echocardiographs and analyzed them using Tomtec system, a vendor independent software (Table [2](#Tab2){ref-type="table"}).

Data collection {#Sec5}
---------------

Clinical and echocardiographic data of interest were extracted by one investigator (HJ) and verified by a second investigator (PI). Mean LS (Longitudinal strain), LSRs (Longitudinal systolic strain rate) as well as deformation measurements at the papillary muscle level including; CS (Circumferential strain), CSRs (Circumferential systolic strain rate), RS (Radial strain) and RSRs (Radial systolic strain rate) were extracted from paper's text or tables. When only segmental measures were available, the global longitudinal strain was calculated by pooling means and variances. A comparison between LV longitudinal segments degree of basal-to-apex gradient was conducted for all studies when available. For any unclear information, we requested additional information from the study investigators and allowed two weeks for them to respond. When they did not respond within two weeks, we used the information available.

After full text revision of preliminary selected studies further filtration was conducted.In the absence of corresponding author's response, studies with incomplete data were not included \[[@CR13]--[@CR15]\] as well as only the largest study of the same author was included \[[@CR16], [@CR17]\].Studies that did not measure longitudinal strain of the whole LV were not included for LS/LSRs analysis \[[@CR18], [@CR19]\].Studies where only Global CS and/or RS were available and the strain at the level of papillary muscles could not be extracted were not included for that analysis \[[@CR20], [@CR21]\].One study was not included due to highly irrelevant data presented \[[@CR22]\].

Quality assessment of studies {#Sec6}
-----------------------------

An adopted Downs and Black score suitable for meta-analysis of normal ranges was used \[[@CR23], [@CR8]\] ([Appendix 1](#Sec19){ref-type="sec"}). Not all included studies represented high level of quality, because of missing some important data for qualitative assessment ([Appendix 2](#Sec20){ref-type="sec"}). However, all studies clearly defined the objectives, the primary outcomes and the main findings. All studies also reported patient characteristics and described the confounding factors even though heart rate, blood pressure and LV mass were only partially reported (Table [1](#Tab1){ref-type="table"}). Standard deviation was used as an Estimate of variability of strain in all studies. Heterogeneity was not determined in any of the studies. In 11 of 28 studies sonographers were blinded to the outcome but individual blindness could not be determined in any study. Intra and inter-observer variability was conducted in 18 studies.Table 1Studies' CharacteristicsArticleAge group StudyYearNoAgeAge groupMales %HRBSA/WeightSBPDBPLV massEDVESVEDDESDControl studiedDisease studiedg/m^2^ml/m^2^ml/m^2^1Bussadori \[[@CR30]\]2009158 ± 2 y5-9 y53Healthy SubjectsHealthy Pediatric Cohort2Pettersen \[[@CR21]\]20092212.7 ± 2.3 y10-14 y631.44 ± 0.24108 ± 1263 ± 758 ± 826 ± 4Healthy ControlsTransposition of the Great Arteries3Jin Yu \[[@CR19]\]2010352.6 ± 1.6 y1-4 y480.59 ± 0.1559.5 ± 12.231.1 ± 519.7 ± 3.3Healthy ControlsKawasaki Disease4Van der Hulst \[[@CR35]\]20101914.1 ± 2.4 y10-14 y631.6 ± 0.395 ± 1042 ± 7Healthy ControlsTetralogy of Fallot5Koh \[[@CR32]\]201095.5 ± 5.5 y5-9 y220.81 ± 0.44Healthy ControlsLeft ventricular non-compaction6Singh \[[@CR41]\]20101415 y15-19 y45751.22 (1.1-1.6)Healthy ControlsSingle ventricle s/p Fontan procedure.7Cheung \[[@CR44]\]20104416.4 ± 6.9 y15-19 y4854.1 ± 11.945 ± 528 ± 4Healthy ControlsAnthracycline Therapy8Takayasu \[[@CR29]\]2011127.4 ± 1.7 y5-9 y6646.7 ± 4.813.5 ± 1.5Healthy ControlsRepaired Tetralogy of Fallot8Takayasu \[[@CR29]\]20111915.5 ± 4.1 y15-19 y7054.9 ± 7.715 ± 2.6Healthy ControlsRepaired Tetralogy of Fallot9Marcus \[[@CR11]\]2011240.3 ± 0.3 y0-1 y541180.32 ± 0.182.8 ± 856 ± 636.2 ± 12.1Healthy SubjectsHealthy Pediatric Cohort9Marcus \[[@CR11]\]2011342.9 ± 1.0 y1-4 y561010.62 ± 0.198 ± 1062 ± 1048.5 ± 11.6Healthy SubjectsHealthy Pediatric Cohort9Marcus \[[@CR11]\]2011367.2 ± 1.2 y5-9 y69840.93 ± 0.12104 ± 870 ± 857.2 ± 12.3Healthy SubjectsHealthy Pediatric Cohort9Marcus \[[@CR11]\]20112912.8 ± 1.6 y10-14 y55771.43 ± 0.23110 ± 1072 ± 859.9 ± 14.2Healthy SubjectsHealthy Pediatric Cohort9Marcus \[[@CR11]\]20112117 ± 1.3 y15-19 y43651.81 ± 0.2116 ± 1075 ± 971.8 ± 16Healthy SubjectsHealthy Pediatric Cohort10Di Salvo \[[@CR34]\]20124511 ± 3 y10-14 y65781.32 ± 0.4107 ± 1461 ± 872 ± 1538.9 ± 6.2Healthy ControlsHeterozygous Familial Hypercholesterolemia11Fernandes \[[@CR45]\]20127110 ± 5 y10-14 yHealthy ControlsTetralogy of Fallot12Poterucha \[[@CR37]\]20121915.3 ± 3 y15-19 y57621.7 ± 0.3119 ± 1248 ± 530 ± 3.4Healthy ControlsAnthracycline Chemotherapy13Hirth \[[@CR43]\]20123411.7 ± 3.8 y10-14 y62701.41 ± 0.3972.3 ± 16.9Healthy ControlsRenal Transplantation in Childhood14Schubert \[[@CR27]\]201330135-207 hNeonates36Healthy NeonatesFetuses15Sehgal \[[@CR17]\]2013212-5 dNeonates3912 gHealthy ControlsAsphyxiated Infants16Klitsie \[[@CR28]\]2013281-3 dNeonates361233500 gHealthy SubjectsHealthy Newborns17Klitsie \[[@CR12]\]2013370.1-0.3 y0-1 y461480.3 ± 0.1Healthy SubjectsHealthy Pediatric Cohort17Klitsie \[[@CR12]\]2013352.3-3.8 y1-4 y541070.6 ± 0.1Healthy SubjectsHealthy Pediatric Cohort17Klitsie \[[@CR12]\]2013376.2-8.2 y5-9 y54880.9 ± 0.2Healthy SubjectsHealthy Pediatric Cohort17Klitsie \[[@CR12]\]20134511.1-13.8 y10-14 y76711.4 ± 02Healthy SubjectsHealthy Pediatric Cohort17Klitsie \[[@CR12]\]20131815.9-16.9 y15-19 y44711.8 ± 0.2Healthy SubjectsHealthy Pediatric Cohort18Singh \[[@CR42]\]20132012.9 y10-14 y45751.22109 ± 1168 ± 5Healthy SubjectsTricuspid Atresia s/p Fontan procedure19Van der Ende \[[@CR5]\]2013408.4 ± 4 y5-9 y531.07 ± 0.34Healthy ControlsAortic Stenosis and Coarctation of Aorta20Dogan \[[@CR31]\]2013526.4 ± 3.8 y5-9 y751010.87 ± 0.3256.1 ± 18.433.8 ± 7.417.8 ± 5.8Healthy ControlsAortic Stenosis21Barbosa \[[@CR36]\]20134611.5 ± 3.1 y10-14 y7490.5 ± 1058.1 ± 6.340.7 ± 5.625.9 ± 3.3Healthy ControlsObese Patients22McCandless \[[@CR40]\]20132212-29 m1-4 y550.48Healthy ControlsKawasaki Disease23Ryan \[[@CR46]\]2013615.2 ± 0.2 y5-9 y10087104 ± 160.9 ± 0.9Healthy ControlsDuchenne Muscular Dystrophy24Simsek \[[@CR38]\]20132016.4 ± 1.8 y15-19 y10065115 ± 1070.5 ± 688 ± 1446.7 ± 4.729.3 ± 4.3Healthy ControlsYoung Elite Athletes25Vitarelli \[[@CR20]\]20144011.3 ± 2.8 y10-14 y5576103 ± 1.667.3 ± 1.454.1 ± 14.157.2 ± 9.541.2 ± 5.3Healthy ControlsHypercholesterolemic and Obese Children26Forsey \[[@CR33]\]2014289.8 ± 4.4 y5-9 y821.16 ± 0.464.3 ± 11.541.8 ± 5.7Healthy ControlsHypertrophic Cardiomyopathy Mutations27Labombarda \[[@CR39]\]20147911.8 ± 3.2 y10-14 y53761.27 ± 0.29109 ± 1162.9 ± 8.142.5 ± 6.7Healthy ControlsDiabetic Children28Binnetoglu \[[@CR16]\]20153115 (11-16) y15-19 y671.48 ± 0.24110 (80-129)60 (48-80)67.7 ± 1342.2 ± 2.4826.1 ± 3.74Healthy ControlsObese Children and Adolescents*HR* heart rate, *BSA* Body surface area, *SBP* systolic blood pressure, *DBP* diastolic blood pressure, *EDV* end diastolic volume, *ESV* end systolic volume, *EDD* end diastolic diameter, *ESD* end systolic diameter

Statistical analysis {#Sec7}
--------------------

The means and 95 % confidence intervals (CI) of LS, LSRs, CS, CSRs, RS, RSRs were calculated using random-effects models weighted by inverse variance \[[@CR24]\]. Between studies heterogeneity was assessed using Cochran's Q test, and inconsistency was measured by I^2^ which is the percentage of total variance across studies attributable to heterogeneity rather than chance \[[@CR25]\]. The influence of different variables such as age, sex, weight (neonates), BSA (body surface area), heart rate, blood pressure, LV mass, LV diameters, LV volumes, frame rate, tissue tracking and vendor on the variation of normal strain measurements was assessed through meta regression, if they were available in at least ten studies.

Statistical analysis was performed using standard software packages (Comprehensive Meta Analysis version 3 software; Biostat inc., Englewood, NJ, USA), with two-tailed P values \<0.05 considered significant. Analysis is presented in forest plots, which is the standard way for illustrating the results of individual studies and meta-analyses. The forest plot was used as a graphical display of the relative strengths of the effect estimates and CIs for each of the individual studies, age groups and the entire meta-analysis \[[@CR26], [@CR8]\]. Publication bias was assessed using funnel plots and Egger's test.

Results {#Sec8}
=======

Our search identified 282 articles. After excluding duplicates and triplicates (n = 97), 185 studies were screened for relevance, from which only 28 fulfilled the inclusion criteria (Fig. [1](#Fig1){ref-type="fig"}). All included articles were in English language, even though no language restriction was applied. Some articles had more than one dataset of different age groups. In total, 34 datasets with 1023 subjects were eligible for meta-analysis of LS \[[@CR27], [@CR17], [@CR28], [@CR12], [@CR11], [@CR29], [@CR30], [@CR5], [@CR31]--[@CR35], [@CR20], [@CR21], [@CR36]--[@CR40], [@CR16], [@CR41]--[@CR44]\] and 12 articles (13 age group studies) with 323 subjects were eligible for meta-analysis of LSRs \[[@CR17], [@CR27], [@CR29], [@CR30], [@CR16], [@CR31], [@CR32], [@CR21], [@CR38], [@CR40], [@CR44], [@CR43]\]. CS was calculated from 16 articles (24 age group studies) \[[@CR28], [@CR12], [@CR11], [@CR19], [@CR31], [@CR30], [@CR32]--[@CR34], [@CR45], [@CR41], [@CR40], [@CR46], [@CR16], [@CR39], [@CR44]\] with a total number of 856 subjects and CSRs was calculated from six articles (six age group studies) with 233 subjects \[[@CR44], [@CR19], [@CR45], [@CR31], [@CR32], [@CR40]\]. 10 articles (18 age group studies) with 701 subjects were eligible for meta-analysis of RS \[[@CR28], [@CR11], [@CR19], [@CR31], [@CR34], [@CR45], [@CR16], [@CR44], [@CR39], [@CR12]\], while RSRs was not calculated because only three studies of different age groups contained the eligible data for meta-analysis (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}).Fig. 1Paper selection flowchartTable 2Echocardiographic characteristicsStudyYearLV measurementsLV model for LS generationSegmental LSEchocardiographic View L/C, RVendorProbe (Mhz)SoftwareFRTissue trackingBussadori \[[@CR30]\]2009L, C (S, SR)6 segmentsYesApical 4CH/BMA saxMyLab 502.5--3.5Xstrain40-64EndocardialPettersen \[[@CR21]\]2009L, C (S, SR)Bull's eyeNoApical 2,3,4 CH/BMA (G) saxGE Vivid 7NSEchoPac69-112EndomyocardialJin Yu \[[@CR19]\]2010C, R (S, SR)N/AN/A/Basal and Mid-level saxGE Vivid 75 and 7EchoPac40-100NSSingh \[[@CR41]\]2010L, C, (S)Bull's eyeYesApical 2,3,4CH/BMA saxGE Vivid 74EchoPac60-90EndomyocardialVan der Hulst \[[@CR35]\]2010L (S)Bull's eyeYesApical 2,3,4 CHGE Vivid 73.5EchoPac\>40EndomyocardialKoh \[[@CR32]\]2010L, C (S, SR)6 segmentsNoApical 4CH/BMA saxGE Vivid 7NSEchoPacNSNSCheung \[[@CR44]\]2010L, C, R (S, SR)6 segmentsNoApical 4CH/Mid-level saxGE Vivid 7NSEchoPacNSNSMarcus \[[@CR11]\]2011L, C, R (S)6 segmentsYesApical 4CH/Basal and Mid-level saxGE Vivid 73 or 5EchoPac70-90EndomyocardialTakayasu \[[@CR29]\]2011L (S, SR)6 segmentsNoApical 4 CHGE Vivid 7UTDEchoPacNSEndomyocardialDi salvo \[[@CR34]\]2012L, C, R (S)6 segmentsYesApical 4CH/BMA saxGE Vivid 71.5-4EchoPac75 (16)EndomyocardialFernandes \[[@CR45]\]2012C, R (S, SR)N/AN/A/BMA saxGE Vivid 7NSEchoPac60-90EndomyocardialPoterucha \[[@CR37]\]2012L (S)Bull's eyeYesApical 2,3,4 CHGE Vivid 7NSEchoPac\>80NSHirth \[[@CR43]\]2012L (S, SR)6 segmentsYesApical 4CHGE Vivid 7UTDEchoPac50NSSchubert \[[@CR27]\]2013L (S, SR)6 segmentsYesApical 4CHGE Vivid 74--10.5EchoPac176-200EndomyocardialSehgal \[[@CR17]\]2013L (S, SR)6 segmentsYesApical 4CHGE Vivid 710EchoPac\>80NSKlitsie \[[@CR28]\]2013L, C, R (S)6 segmentsNoApical 4CH/Mid-level saxGE Vivid 7NSEchoPacNSEndomyocardialKlitsie \[[@CR12]\]2013L, C, R (S)6 segmentsNoApical 4CH/Mid-level saxGE Vivid 7NSEchoPac60-80EndomyocardialSingh \[[@CR42]\]2013L (S)Bull's eyeNoApical 2,3,4CHGE Vivid 71.5-4EchoPacNSNSVan der Ende \[[@CR5]\]2013L (S)Bull's eyeYesApical 2,3,4CHGE Vivid 7NSEchoPac\>45NSDogan \[[@CR31]\]2013L, C, R (S, SR)6 segmentsYesApical 4 CH/Mid-level saxGE Vivid 73.0 and 7.5EchoPac\>60EndomyocardialBarbosa \[[@CR36]\]2013L (S)Bull's eyeNoApical 2,3,4 CHGE Vivid 7NSEchoPac44NSRyan \[[@CR46]\]2013C (S)N/AN/A/Mid-level saxMixNSTomtec75EndomyocardialMcCandless \[[@CR40]\]2013L, C (S, SR)6 segmentsYesApical 4CH/Mid-level saxSiemensNSSyngoNSEndocardialSimsek \[[@CR38]\]2013L (S, SR)Bull's eyeNoApical 2,3,4 CHGE Vivid 72.5EchoPac60-100NSVitarelli \[[@CR20]\]2014L, C, R (S)Bull's eyeNoApical 2,3,4 CH/BMA (G) saxGE Vivid E91.4-4.6EchoPac\>50NSForsey \[[@CR33]\]2014L, C (S)6 segmentsYesApical 4CH/BMA saxGE Vivid 7NSEchoPac33-129EndomyocardialLabombarda \[[@CR39]\]2014L, C, R (S)6 segmentsNoApical 2,3,4CH/Mid-level saxPhilips iE331-5QLabNSEndo-EpicardialBinnetoglu \[[@CR16]\]2015L, C, R (S)6 segmentsYesApical 4 CH/Mid-level saxGE Vivid 7NSEchoPac60-90NS*L* Longitudinal, *C* Circumferential, *R* Radial, *S* Strain, *SR* Strain rate, *CH* Chamber view, *FR* Frame rate, *BMA* Basal, medium and apical level, *BMA* (*G*) only global strain value available, *Mix* three different vendors used (GE, Philips and Acuson), *sax* short axis, *NS* not specified, *UTD* unable to determine

Normal ranges {#Sec9}
-------------

### LV longitudinal myocardial deformation {#Sec10}

Normal mean values of LS for all 34 age group studies combined varied from -12.9 to -26.5 (mean, -20.5; 95 % CI, -20.0 to -21.0). Overall study heterogeneity (within and between age group studies) as shown by Cochran's Q test was 596 (*p* \< 0.0001) and inconsistency by I^2^ was 94.47 % (Fig. [2](#Fig2){ref-type="fig"}). The meta-regression analysis showed that the LVEDD (left ventricular end-diastolic diameter) (β = 0.3; 95 % CI, 0.13 to 0.47; *p* \< 0.001) and probe frequency (β = -0.7; 95 % CI, -1.29 to -0.1; *p* = 0.02) were the only significant determinants of variations between reported ranges of LS measurements (Table [3](#Tab3){ref-type="table"}). There was no evidence for publication bias (*p* = 0.88) as shown by the Egger's test for the LS (Fig. [3](#Fig3){ref-type="fig"}).Fig. 2Normal value of LS. The forest plot lists the names of the studies in subgroups. The means and CIs including the results for variance, used in the inverse variance correction are shownTable 3Meta-regression results (p values). Significant p-values are bolded for emphasisLSLSRsCSRSVariableb (95 % CI)pb (95 % CI)pb (95 % CI)pb (95 % CI)pAge0.06 (-0.03 to 0.16)0.180.04 (0.02 to 0.05)**\<0.001**-0.07 (-0.26 to -0.11)0.450.16 (-1.01 to 1.33)0**.**78Male gender0.02 (-0.02 to 0.06)0.310.002 (-0.004 to 0.009)0.49-0.01 (-0.07 to 0.05)0.760.13 (-0.7 to 0.95)0.75BSA-0.24 (-1.64 to 1.15)0.73-1.71 (-4.25 to 0.82)0.180.14 (-15.59 to 15.87)0.98HR-0.004 (-0.03 to 0.02)0.760.01 (-0.02 to 0.06)0.48-0.12 (-0.46 to 0.21)0.47SBP-0.02 (-0.08 to 0.04)0.51DBP-0.08 (-0.18 to 0.02)0.13LVEDD0.3 (0.13 to 0.47)**\<0.001**LV mass0.01 (-0.05 to 0.08)0.57-0.03 (-0.22 to 0.15)0.71LV model0.99 (-0.18 to 2.17)0.10.32 (-0.1 to 0.75)0.14Tissue tracking-0.68 (-1.79 to 0.42)0.22Vendor0.92 (-0.07 to 1.92)0.080.15 (-0.1 to 0.41)0.250.59 (-0.36 to 1.56)0.22-6.59 (-11.3 to -1.91)**0.005**Probe-0.70 (-1.29 to -0.1)**0.02**1.36 (-0.08 to 2.81)0.07FR0.007 (-0.01 to 0.03)0.51-0.001 (-0.006 to 0.002)0.400.07 (-0.09 to 0.23)0.380.55 (-0.71 to 1.82)0.39Fig. 3Funnel plot for studies of LS

Normal values for LSRs for all 13 data sets combined varied from -0.9 to -2.7 (Mean, -1.3; 95 % CI, -1.2 to -1.4) (Fig. [4](#Fig4){ref-type="fig"}). Overall heterogeneity was 387 (*p* \< 0.0001) and inconsistency was 96.9 %. Meta-regression of variables available in more than 10 studies, showed age as the only significant determinant of LSRs variations (β = 0.04; 95 % CI 0.02 to 0.05; *p* \< 0.001). In addition, Egger's test for LSRs suggested significant publication bias (p = 0.011). However, even after using Duval and Tweedie's trim and fill, and adjusting the effect size for funnel plot asymmetry the adjusted effect was the same to the original effect.Fig. 4Normal value of LSRs. The forest plot lists the names of the studies in subgroups. The means and CIs including the results for variance, used in the inverse variance correction are shown

### LV circumferential myocardial deformation {#Sec11}

Normal mean values of CS for all 24 age group studies combined varied from -10.5 to -27.0 (mean, -22.06; 95 % CI, -21.5 to -22.5) (Fig. [5](#Fig5){ref-type="fig"}). Overall study heterogeneity was 599 (*p* \< 0.0001) and inconsistency was 96.1 %. Meta-regression analysis did not find any significant determinant of variation among variables present in more than ten studies. There was no evidence for publication bias (*p* = 0.85).Fig. 5Normal value of CS. The forest plot lists the names of the studies in subgroups. The means and CIs including the results for variance, used in the inverse variance correction are shown

CSRs meta-analysis from six datasets of different age groups varied from -0.84 to -1.84 (mean, -1.33; 95 % CI, -1.27 to -1.39) (Fig. [6](#Fig6){ref-type="fig"}). Cochran Q test showed an overall study heterogeneity of 133 (*p* \< 0.001) and I^2^ showed inconsistency of 96.25 %. Meta-regression analysis was not conducted due to small number of available studies (less than ten). There was no evidence for publication bias (*p* = 0.52).Fig. 6Normal value of CSRs. The forest plot lists the names of the studies in subgroups. The means and CIs including the results for variance, used in the inverse variance correction are shown

### LV radial myocardial deformation {#Sec12}

RS meta-analysis from 18 datasets of different age groups varied from 24.9 to 62.1 (mean, 45.4; 95 % CI, 43.0 to 47.8) (Fig. [7](#Fig7){ref-type="fig"}). Overall study heterogeneity was 1764 (*p* \< 0.0001) and inconsistency was 99.03 %. Vendor was the only significant determinant of inter-study variability (*p* = 0.005). There was no evidence for publication bias (*p* = 0.122). Three studies of different age groups were not enough for meta-analysis of RSRs.Fig. 7Normal value of RS. The forest plot lists the names of the studies in subgroups. The means and CIs including the results for variance, used in the inverse variance correction are shown

Even though all myocardial deformation parameters seemed to differ between age groups, only LSRs was significantly affected by the age of children with β = 0.04 (CI 0.02 to 0.05; *p* \< 0.001). In addition, only RS resulted to be significantly influenced by the change of vendor (*p* = 0.005).

Of the LV volumes and dimensions, the LVEDD effect on LS was the only variable tested, because others were scarcely reported. LS decreased as the LVEDD increased. Higher probe frequencies were significantly related to higher LS values (*p* = 0.02). However, it turned insignificant in a bivariate model together with age (*p* = 0.07). Furthermore, examination of the LS forest plot also suggested higher variability in the neonates and infants. Low number of studies in these age groups might also play role for such variability.

There was no difference between longitudinal strain values generated by two different models, global longitudinal strain (bull's eye model) and six-segment longitudinal strain model (-19.9 ± 0.6 vs. -20.9 ± 0.3; *p* = 0.1). Moreover, variables such as BSA, HR, SBP, DBP, LV mass, tissue tracking and FR did not significantly affected tested parameters.

Regional longitudinal strain {#Sec13}
----------------------------

Segmental strain values were available in 18 datasets. Of these, four used bull's eye model and 14 used six-segment model. Even though, an increasing longitudinal strain from base towards apex is noticed, it was not significant for all group ages together (--19.8 % vs. -20.27 % vs. -21.27 %; *p* = 0.15). Also, in the meta-regression analysis we found that age did not significantly affect the base-to-apex gradient (*p* = 0.53). However, when analyzing LS in individual age groups, significant base-to-apex gradient was evident in 5-9 and 10-14 years age groups (*p* \< 0.0001 and *p* = 0.003, respectively).

The type of vendor and tissue tracking used were just about to significantly affect the base-to-apex gradient (*p* = 0.07 and *p* = 0.06). However, since all vendors other than GE reporting on base-to-apex gradient used endocardial in spite of endomyocardial tissue tracking, such influence could not be determined if it is vendor or tissue tracking dependent. In addition, BSA, HR, SBP, DBP, LV mass, probe frequency, model used to generate LV strain and FR did not significantly affected base-to-apex gradient.

Discussion {#Sec14}
==========

Normal ranges {#Sec15}
-------------

Deformation parameters are shown to be able to detect early subclinical dysfunction of the LV in various congenital and acquired heart diseases in children. Most of the studies have reported longitudinal strain, a very sensitive parameters of subendocardial dysfunction. In addition, evaluation of circumferential and radial strain is also important when assessing compensation patterns of LV function \[[@CR6]\]. However, lack of a normal range of values and associated variation hinder their use for everyday clinical evaluation. This is the first study that defines LV normal strain values in children and which evaluates demographic, clinical and echocardiographic parameters as possible confounding factors through a meta-analysis. Many studies have reported normal strain values from relatively small population used as healthy control in their studies. However, combining those studies in a meta-analysis provides more reliable values of normal range than any individual study alone.

The base-to-apex LS gradient seems to emerge as children grow up. During neonatal period, there are no significant difference in longitudinal strain between LV base, mid cavity and apex. Moreover, one study has shown a decrease of base-to-apex gradient in neonates \[[@CR27]\]. Even though, base-to-apex gradient can be noticed from early infancy, significant differences in segmental myocardial strain appear only in 5-9 and 10-14 years age groups.

Source of bias {#Sec16}
--------------

The meta-regression in our study showed that the vendor significantly determined the variations in RS values. In contrast, Yingchoncharoen et al. \[[@CR9]\] in a meta-analysis of LV strain in adults refuted the role of vendor as an independent factor for differences in strain values between reports. However, earlier reports have stressed the importance of vendor variability for RS in particular \[[@CR10], [@CR47]\]. Therefore, since GE is the most used echocardiograph, RS normal ranges for GE vendor only are presented in [Appendix 3](#Sec21){ref-type="sec"}. The higher variation in circumferential and radial strain values may be due to differences in resolution as well as spatial and temporal variation in scan-line sequencing. Smaller number of speckles (smaller area) of short axis views together with epicardial border tracking difficulties due to respiratory lung artifacts may also play a role. However, since the same degree of variability applies to all speckles, higher magnitude of variability happens to higher deformation values (radial strain) \[[@CR10], [@CR47]\].

Age is also another factor that influenced LSRs measures. Even though, LS, CS and RS are not significantly influenced by age, they demonstrated only a trend. Because individual studies were allocated on different age groups, the overlap of large standard deviations might explain the lack of significance when mean values were compared. We have also found large variability between neonates and infants as shown in the forest plots. This could be explained by the high sensitivity of the myocardium to changes in afterload \[[@CR48]\]. Indeed, several hemodynamic changes occur during early neonatal life. Closure of the ductus arteriosus, with subsequent increase of pulmonary blood flow, increases preload. A postnatal afterload increase could also be related to the shifting from the low-resistance placental circulation to the increased systemic arterial blood pressure. Such dynamic changes in loading conditions are expected to influence myocardial deformation \[[@CR11], [@CR49]\]. In addition, lower and more variable strain values in infants could be explained on the basis of histological and physiological changes occurring early in life \[[@CR50]--[@CR52]\]. The neonatal myocardium is immature with less cellular (mitochondrial) and structural (myofibril) organization and contractile proteins \[[@CR49]\] as well as higher Type I/Type III collagen ratio (stiffer) than adults \[[@CR53]\]. These changes are believed to mature by 6-12 months of age, but adult values are not reached until adolescence. In addition, neonatal period is characterized by dynamic changes in multiple hormone systems \[[@CR54]\]. Despite the small available evidence, gradually switching in energy substrate preference of the heart from fetal carbohydrates to fatty acid oxidation is another likely factor that influences cardiovascular function \[[@CR55]\].

LS has been shown to be related to LV dimension and volume, the latter was rarely reported hence no meta-regression analysis is available. LV diastolic dimensions have been shown to inversely correlate with LS in patients with volume overload e.g. mitral regurgitation highlighting the potential need for correcting such measurements to changes in LV dimensions \[[@CR56]\]. On the other hand, using 3D speckle tracing a positive correlation has been found between LV end systolic volumes and global CS in children \[[@CR57]\] and between LV volume z-scores and LS \[[@CR18]\].

Finally, the effect of heart rate, gender, body surface area, blood pressure, left ventricle mass, frame rate, tissue tracking, probe frequency and LV model of generating strain were proposed but not strongly proven. However, earlier findings \[[@CR10]\] reported frame rate to significantly influence strain parameters, with the best reproducibility using frame rate to heart rate ratio between 0.7 and 0.9 frames/sec per beat/min \[[@CR58]\]. The influence of blood pressure \[[@CR9]\] and heart rate \[[@CR59]\] on LV strain values is also reported.

Limitations {#Sec17}
===========

Low number of studies to conduct meta-analysis of systolic strain rate for CS and RS is a limitation in this report, particularly early and late diastolic strain rate, which were not consistently measured. Blood pressure, LV mass, volumes, diameters and probe frequency were reported in very few studies, hence regression analysis could not be conducted for all parameters. The small number of studies using vendors other than GE might affect the regression-analysis of vendor on strain parameters because of insufficient heterogeneity. Since, STE is not user independent, the operator's expertise might affect the values. Heterogeneity might not be seen as a limitation in meta-analysis when a pooled estimate is the main objective.

Conclusion {#Sec18}
==========

In normal healthy children, the mean LS value is -20.5 (95 % CI, -20.0 to -21.0), mean LSRs is -1.3 (95 % CI, -1.2 to -1.4), mean CS is -22.06 (95 % CI, -21.54 to -22.55), mean CSRs is -1.33 (95 % CI, -1.27 to -1.39) and mean RS is 45.47 (95 % CI, 43.07 to 47.88). Variations among different normal ranges were dependent on the vendor used, LV end-diastolic dimension and age. Vendor-independent software for analyzing myocardial deformation in children, using images from different vendors would be the ideal solution for strain measurements or else using the same system for patient's follow up.

Appendix 1 {#Sec19}
==========

Table 4Qualitative assessment of study reportingDescription of criteriaPossible answersIs the hypothesis/aim/objective of the study clearly described?Yes/NoAre the main outcomes to be measured clearly described in the [Introduction](#Sec1){ref-type="sec"} or [Methods](#Sec3){ref-type="sec"} section?Yes/NoAre the characteristics of the patients included in the study clearly described?Yes/NoAre the distributions of principal confounders clearly described?Yes/NoAre the main findings of the study clearly described?Yes/NoDoes the study provide estimates of the random variability in the data for the main outcomes?Yes/NoWere the subjects asked to participate in the study representative of the entire population from which they were recruited?Yes/No/UTDWas an attempt made to blind those measuring the main outcomes of the intervention?Yes/No/UTDWas reproducibility analysis performed?Yes/No

Appendix 2 {#Sec20}
==========

Table 5Qualitative data for eligible studiesStudyYearObjective defined?Outcomes described?Characteristics described?Confounders described?Main findings described?Estimates of variability?Heterogeneous population?Sonographer(s) blinded?Reproducibility performed?Bussadori \[[@CR30]\]2009YesYesYesYesYesYesUTDYesYesPettersen \[[@CR21]\]2009YesYesYesYesYesYesUTDUTDYesJin Yu \[[@CR19]\]2010YesYesYesYesYesYesUTDYesYesSingh \[[@CR41]\]2010YesYesYesYesYesYesUTDUTDYesVan der Hulst \[[@CR35]\]2010YesYesYesYesYesYesUTDUTDNoKoh \[[@CR32]\]2010YesYesYesYesYesYesUTDUTDNoCheung \[[@CR44]\]2010YesYesYesYesYesYesUTDUTDNoMarcus \[[@CR11]\]2011YesYesYesYesYesYesUTDYesYesTakayasu \[[@CR29]\]2011YesYesYesYesYesYesUTDUTDYesDi salvo \[[@CR34]\]2012YesYesYesYesYesYesUTDUTDYesFernandes \[[@CR45]\]2012YesYesYesYesYesYesUTDYesNoPoterucha \[[@CR37]\]2012YesYesYesYesYesYesUTDYesYesHirth \[[@CR43]\]2012YesYesYesYesYesYesUTDYesYesSchubert \[[@CR27]\]2013YesYesYesYesYesYesUTDUTDYesSehgal \[[@CR17]\]2013YesYesYesYesYesYesUTDYesYesKlitsie \[[@CR28]\]2013YesYesYesYesYesYesUTDUTDNoKlitsie \[[@CR12]\]2013YesYesYesYesYesYesUTDYesYesSingh \[[@CR42]\]2013YesYesYesYesYesYesUTDUTDNoVan der Ende \[[@CR5]\]2013YesYesYesYesYesYesUTDUTDYesDogan \[[@CR31]\]2013YesYesYesYesYesYesUTDUTDNoBarbosa \[[@CR36]\]2013YesYesYesYesYesYesUTDUTDYesRyan \[[@CR46]\]2013YesYesYesYesYesYesUTDYesYesMcCandless \[[@CR40]\]2013YesYesYesYesYesYesUTDUTDNoSimsek \[[@CR38]\]2013YesYesYesYesYesYesUTDYesYesVitarelli \[[@CR20]\]2014YesYesYesYesYesYesUTDUTDNoForsey \[[@CR33]\]2014YesYesYesYesYesYesUTDYesYesLabombarda \[[@CR39]\]2014YesYesYesYesYesYesUTDUTDYesBinnetoglu \[[@CR16]\]2015YesYesYesYesYesYesUTDUTDNo*UTD* unable to determine

Appendix 3 {#Sec21}
==========

Table 6Normal range of values for GE vendorLS (95 % CI)LSRs (95 % CI)CS (95 % CI)CSRs (95 % CI)RS (95 % CI)Neonates-21.0 (-17.3 to -24.7)-2.1 (-1.5 to -2.6)-19.7 (-18.1 to -21.3)29.4 (24.9 to 33.9)0-1 y-19.3 (-17.3 to -21.2)-20.1 (-17.1 to -23.1)46.3 (35.0 to 57.5)1-4 y-21.7 (-19.7 to -23.8)-19.8 (-16.2 to -23.3)-1.73 (-1.62 to -1.83)53.3 (50.0 to 56.7)5-9 y-22.7 (-21.5 to -23.9)-1.6 (-1.5 to -1.8)-22.9 (-22.5 to -23.4)-1.66 (-1.55 to -1.77)48.6 (39.4 to 57.8)10-14 y-20.0 (-19.2 to -20.9)-1.2 (-1.0 to -1.4)-21.3 (-19.6 to -23.1)-1.51 (-1.39 to -1.62)52.4 (47.4 to 57.3)15-19 y-19.8 (-18.5 to -21.0)-1.2 (-1.0 to -1.4)-19.9 (-16.8 to -23.0)-1.06 (-0.97 to -1.14)47.6 (37.0 to 58.1)Overall-20.6 (-20.1 to -21.2)-1.4 (-1.3 to -1.5)-22.5 (-22.0 to -22.9)-1.42 (-1.37 to -1.47)46.8 (44.6 to 48.9)

LV

:   Left ventricle/ ventricular

2D STE

:   Two-dimensional speckle-tracking echocardiography

2D

:   Two-dimensional

LS

:   Longitudinal strain

LSRs

:   Longitudinal systolic strain rate

CS

:   Circumferential strain

CSRs

:   Circumferential systolic strain rate

RS

:   Radial strain

RSRs

:   Radial systolic strain rate

CI

:   Confidence interval

BSA

:   Body surface area

FR

:   Frame rate

LVEDD

:   Left ventricular end diastolic diameter
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